A screen for epigenetic regulators of hematopoiesis reveals a requirement for the Hbo1 complex during hematopoietic stem cell specification
造血表观遗传调节因子的筛选揭示了造血干细胞特化过程中对 Hbo1 复合物的需求
基本信息
- 批准号:8867682
- 负责人:
- 金额:$ 15.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-13 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcetyltransferaseAdultAnimal ModelAwardBindingBinding SitesBiologyBloodBlood CellsBone Marrow TransplantationBostonCD34 geneCell Differentiation processCell LineageCell modelCellsChIP-seqChromatinChromatin Remodeling FactorChromatin StructureCodeComplexCytokine SignalingDefectDevelopmentEmbryoEndotheliumEnsureEnvironmentEpigenetic ProcessErythroid CellsFamily memberFertilizationGene ExpressionGene Expression RegulationGenesGeneticGenetic ScreeningHematological DiseaseHematologistHematologyHematopoiesisHematopoieticHematopoietic stem cellsHistone CodeHistonesHomeostasisHourHumanIn Situ HybridizationIndividualInflammatoryKnowledgeLaboratoriesLeadLymphoid CellMYB geneMaintenanceMarrowMentorsMentorshipMolecularMusMutationMyeloid CellsNF-kappa BNFKB Signaling PathwayNuRD complexOrthologous GenePathway interactionsPatientsPediatric HospitalsPolycombPost-Translational Protein ProcessingProcessProliferatingProteinsRegulationResearchResearch PersonnelResearch Project GrantsResearch TrainingRoleScientific Advances and AccomplishmentsScientistSeedsSickle Cell AnemiaSignal PathwaySignal TransductionSiteStem Cell DevelopmentStem cellsThalassemiaTherapeuticTissuesTo specifyTrainingTraining ProgramsTransplantationUmbilical Cord Blood TransplantationWorkZebrafishblastocystchromatin remodelingdesignhematopoietic stem cell fatehistone modificationin vivomedical schoolsmembernoveloncologyoverexpressionpreventpublic health relevanceresponsereverse geneticsself-renewalskillsstem cell differentiationstem cell fate specificationsuccesstherapeutic targettooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): Long-term hematopoietic stem cells (HSCs) are capable of self- renewal and differentiation into all mature hematopoietic lineages. Cell specific transcription factors interact with co-factors to orchestrate chromatin structure and facilitate gene expression. To generate a compendium of factors that establish the epigenetic code in HSCs, I completed first large-scale in vivo reverse genetic screen targeting chromatin factors. To accomplish this task, I designed antisense morpholinos for 488 zebrafish orthologs of conserved human chromatin factors and the resultant morphants were analyzed by whole embryo in situ hybridization at 36 hours post fertilization for expression of two HSC specific genes, c- myb and runx1. 25 morpholinos caused near complete knockdown of HSC marker expression and 4 were found to increase HSC marker expression. Of the morpholinos that alter formation, several genes known to be essential for HSC self-renewal and maintenance were identified. For example, knockdown of Mll or Dot1 fail to specify HSCs, as indicated by a reduction in expression of the HSC markers. Reduced expression of six polycomb family members results in a decrease in HSC marker expression. Many of the remaining hits represent factors with no previous function ascribed in hematopoiesis, though some are components of known chromatin remodeling complexes, such as the Hat1 and Hbo1 complexes. The Hbo1 complex binds to target loci through one of the complex members, Ing4, which recognizes H3K4me3 marks. Four members of the Hbo1 complex were hits in this screen and I have found that these factors genetically interact in zebrafish embryos. No role for this complex has been shown previously in HSCs. Ing4 has also been shown to negatively regulate NF-B, tying the function of this complex to regulation of inflammatory signals in HSCs. This project will connect two important pathways, chromatin remodeling through acetylation and HSC response to inflammatory signals, offering new avenues to pursue in the study of histone modifications in HSCs and for therapeutic alternatives for patients with blood disorders. As a postdoctoral Research Fellow in Hematology/Oncology at the Children's Hospital Boston, Dr. Kathrein will perform her research project in the laboratory of Dr. Leonard Zon, a renowned hematologist, stem cell biologist, and zebrafish researcher. Building on her strong background of studying cell signaling mechanisms, Dr. Kathrein will expand her advanced scientific and technical knowledge to the regulation of hematopoietic cell specification determination using zebrafish as model organism. Under the mentorship of Dr. Zon and a prestigious mentoring committee, Dr. Kathrein has developed an ambitious research and training program that will equip her with highest research skills to ensure her success in the mentored and independent award period. The nurturing environment of the Children's Hospital Boston and the Harvard Medical School will provide the perfect surroundings for Dr. Kathrein's training to become a successful independent scientist.
描述(由申请人提供):长期造血干细胞(HSC)能够自我更新并分化为所有成熟的造血谱系。细胞特异性转录因子与辅因子相互作用以协调染色质结构并促进基因表达。为了生成在HSC中建立表观遗传密码的因子的概要,我完成了第一次大规模的针对染色质因子的体内反向遗传筛选。为了完成这一任务,我设计了488个斑马鱼同源的人染色质保守因子的反义吗啉代,并在受精后36小时通过全胚胎原位杂交分析了所得吗啉代的两个HSC特异性基因c-myb和runx 1的表达。25个吗啉代导致HSC标记物表达的几乎完全敲低,并且发现4个增加HSC标记物表达。在改变形成的吗啉代中,确定了已知对HSC自我更新和维持至关重要的几个基因。例如,MII或Dot 1的敲低不能指定HSC,如HSC标志物表达的减少所示。六个polycomb家族成员的表达减少导致HSC标志物表达减少。许多剩余的命中代表的因素没有以前的功能归因于造血,虽然有些是已知的染色质重塑复合物,如Hat 1和Hbo 1复合物的组成部分。Hbo 1复合物通过复合物成员之一Ing 4与靶基因座结合,Ing 4识别H3 K4 me 3标记。Hbo 1复合物的四个成员在这个屏幕上被击中,我发现这些因子在斑马鱼胚胎中遗传相互作用。以前在HSC中没有显示这种复合物的作用。Ing 4还显示负调节NF-κ B B,将该复合物的功能与HSC中炎症信号的调节联系起来.该项目将连接两个重要的途径,通过乙酰化和HSC对炎症信号的反应进行染色质重塑,为研究HSC中的组蛋白修饰和血液疾病患者的治疗选择提供新的途径。作为波士顿儿童医院血液学/肿瘤学博士后研究员,Kathrein博士将在伦纳德Zon博士的实验室进行她的研究项目,他是著名的血液学家、干细胞生物学家和斑马鱼研究员。Kathrein博士将在她研究细胞信号传导机制的强大背景的基础上,将她先进的科学和技术知识扩展到以斑马鱼为模式生物的造血细胞规格确定的调节。在Zon博士和一个著名的指导委员会的指导下,Kathrein博士制定了一个雄心勃勃的研究和培训计划,这将使她具备最高的研究技能,以确保她在指导和独立奖励期间取得成功。波士顿儿童医院和哈佛医学院的培养环境将为凯瑟琳博士的培训提供完美的环境,使其成为一名成功的独立科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katie L Kathrein其他文献
Ing4-Deficiency Confers Resistance to Inflammatory Stress through Enhanced Hematopoietic Stem Cell Quiescence
- DOI:
10.1182/blood-2022-170873 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Zanshé Thompson;Georgina A Anderson;Melanie Rodriguez;Seth Gabriel;Vera Binder;Alison M Taylor;Katie L Kathrein - 通讯作者:
Katie L Kathrein
Katie L Kathrein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katie L Kathrein', 18)}}的其他基金
Ing4-deficiency enhances the regenerative capacity of multipotent progenitor cells
Ing4缺陷增强多能祖细胞的再生能力
- 批准号:
10452422 - 财政年份:2022
- 资助金额:
$ 15.41万 - 项目类别:
Ing4-deficiency enhances the regenerative capacity of multipotent progenitor cells
Ing4缺陷增强多能祖细胞的再生能力
- 批准号:
10574574 - 财政年份:2022
- 资助金额:
$ 15.41万 - 项目类别:
A screen for epigenetic regulators of hematopoiesis reveals a requirement for the Hbo1 complex during hematopoietic stem cell specification
造血表观遗传调节因子的筛选揭示了造血干细胞特化过程中对 Hbo1 复合物的需求
- 批准号:
9247893 - 财政年份:2015
- 资助金额:
$ 15.41万 - 项目类别:
Remediating Ing4 tumor suppressor deficiency using a zebrafish model
使用斑马鱼模型修复 Ing4 肿瘤抑制因子缺陷
- 批准号:
10221722 - 财政年份:2014
- 资助金额:
$ 15.41万 - 项目类别:
Remediating Ing4 tumor suppressor deficiency using a zebrafish model
使用斑马鱼模型修复 Ing4 肿瘤抑制因子缺陷
- 批准号:
10403538 - 财政年份:2014
- 资助金额:
$ 15.41万 - 项目类别:
Epigenetic Regulation of Hematopoietic Stem Cell Specification
造血干细胞规格的表观遗传调控
- 批准号:
8000698 - 财政年份:2010
- 资助金额:
$ 15.41万 - 项目类别:
Remediating Ing4 tumor suppressor deficiency using a zebrafish model
使用斑马鱼模型修复 Ing4 肿瘤抑制因子缺陷
- 批准号:
9978929 - 财政年份:
- 资助金额:
$ 15.41万 - 项目类别:
Remediating Ing4 tumor suppressor deficiency using a zebrafish model
使用斑马鱼模型修复 Ing4 肿瘤抑制因子缺陷
- 批准号:
9794387 - 财政年份:
- 资助金额:
$ 15.41万 - 项目类别:
相似海外基金
Dissecting out differential molecular phenotypes across Lysine(K) AcetylTransferase mutations in mouse development
剖析小鼠发育过程中赖氨酸(K)乙酰转移酶突变的差异分子表型
- 批准号:
10727966 - 财政年份:2023
- 资助金额:
$ 15.41万 - 项目类别:
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
靶向赖氨酸乙酰转移酶 MOF/KAT8 在肺癌中的作用
- 批准号:
10601761 - 财政年份:2023
- 资助金额:
$ 15.41万 - 项目类别:
Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder
定义组蛋白乙酰转移酶 KAT2a 在伏隔核 D1 中型多棘神经元中作为可卡因使用障碍驱动因素的细胞类型特异性作用
- 批准号:
10679238 - 财政年份:2023
- 资助金额:
$ 15.41万 - 项目类别:
Roles of lysine acetyltransferase 6 complexes in cerebral development and neurodevelopmental disorders
赖氨酸乙酰转移酶 6 复合物在大脑发育和神经发育障碍中的作用
- 批准号:
479754 - 财政年份:2023
- 资助金额:
$ 15.41万 - 项目类别:
Operating Grants
Examination of the Histone Acetyltransferase CBP in the Remodelling of Thermogenic Adipose Tissues
组蛋白乙酰转移酶 CBP 在生热脂肪组织重塑中的检测
- 批准号:
486467 - 财政年份:2022
- 资助金额:
$ 15.41万 - 项目类别:
Studentship Programs
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10344246 - 财政年份:2022
- 资助金额:
$ 15.41万 - 项目类别:
Nuclear activity of carnitine acetyltransferase
肉毒碱乙酰转移酶的核活性
- 批准号:
RGPIN-2018-06089 - 财政年份:2022
- 资助金额:
$ 15.41万 - 项目类别:
Discovery Grants Program - Individual
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10627744 - 财政年份:2022
- 资助金额:
$ 15.41万 - 项目类别:
Structural and functional studies of histone acetyltransferase complexes
组蛋白乙酰转移酶复合物的结构和功能研究
- 批准号:
RGPIN-2018-03951 - 财政年份:2022
- 资助金额:
$ 15.41万 - 项目类别:
Discovery Grants Program - Individual
Characterizing the role of the NuA3 histone acetyltransferase complex during transcription
表征 NuA3 组蛋白乙酰转移酶复合物在转录过程中的作用
- 批准号:
557615-2021 - 财政年份:2022
- 资助金额:
$ 15.41万 - 项目类别:
Postdoctoral Fellowships